Serum Serotonin Abnormality in Depression

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Serotonin is a key neurotransmitter implicated in the pathophysiology and treatment of depression.
• Understanding the relationship between serotonin levels and treatment response is crucial for managing depressive disorders.

Purpose of the Study:

• To investigate the clinical correlates of plasma serotonin levels in patients with depression before and after treatment.
• To examine the association between serotonin levels and depression/suicidal ideation severity.

Main Methods:

• A study included 40 patients diagnosed with depression (ICD-10) and 40 healthy controls.
• Beck's Depression Inventory (BDI) and Suicide Ideation Scale (SIS) were used for clinical assessments.
• Plasma serotonin levels were measured before and after treatment with selective serotonin reuptake inhibitors (SSRIs).

Main Results:

• Significant improvements were observed in BDI and SIS scores, as well as plasma serotonin levels, after SSRI treatment (p<.000).
• No significant correlation was found between pre- and post-treatment serotonin levels and changes in rating scale scores (p > 0.05).
• Patients with suicidal ideation exhibited lower baseline serotonin levels.

Conclusions:

• Treatment with SSRIs significantly improved the clinical condition of depressed patients.
• Despite clinical improvements, the changes in serum serotonin levels did not show a significant association with the observed therapeutic effects.